FITC Rat Anti-Mouse CD39 Antibody (S-R641)

產(chǎn)品型號(hào)：S0B5399

更新時(shí)間：2025-10-09

廠商性質(zhì)：生產(chǎn)廠家

訪問量：58

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

乳腺病理免疫組化解碼：從標(biāo)記物判讀到陷阱規(guī)避全指南

成纖維細(xì)胞生長因子-1（FGF1）如何重編程疾病命運(yùn)與國自然研究新范式

大鼠免疫球蛋白的免疫功能及應(yīng)用價(jià)值

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風(fēng)險(xiǎn)中的診斷潛力

產(chǎn)品介紹

CD39, also known as ectonucleoside triphosphate diphosphohydrolase-1 （ENTPD1）, is a membrane-bound enzyme that hydrolyzes extracellular nucleotides such as ATP and ADP into AMP in a Ca2?- and Mg2?-dependent manner. It plays a crucial role in regulating immune responses and vascular function. In the tumor microenvironment, CD39 works with CD73 to convert ATP into adenosine, an immunosuppressive molecule that inhibits the activity of effector immune cells while promoting the function of regulatory immune cells, thus contributing to tumor immune evasion. This protein is highly expressed in various cell types within the tumor microenvironment, including tumor cells, stromal cells, endothelial cells, and immune cells. CD39 is also involved in thromboregulation and has been identified as a potential therapeutic target for cancer immunotherapy.

上一個(gè)：S0B5398FITC Rat Anti-Mouse CD43 Antibody (S-R588)